Form 4 filings across 3 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: $0
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 6 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 16 most recent Form 4 transactions.
| Aug 5 |
| JAZZ |
| Jazz Pharmaceuticals plc |
| AGRANT |
| 1,605 |
| — |
| — |
| +23.2% |
| Open the original filing on SEC.gov |
| Jun 12 | FATE | Fate Therapeutics INC | AGRANT◆ | 175,800 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 33,450 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 14,545 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 13,950 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 16,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 11,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS◆ | 27,000 | — | — | — | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | DTOISS | 25,080 | — | — | -100.0% | Open the original filing on SEC.gov |
| Sep 16, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | UTENDR | 5,825 | $8.60 | $50.1K | -100.0% | Open the original filing on SEC.gov |
| Aug 8, 2025 | JAZZ | Jazz Pharmaceuticals plc | FTAX | 1,805 | $111.25 | $200.8K | -20.7% | Open the original filing on SEC.gov |
| Aug 7, 2025 | JAZZ | Jazz Pharmaceuticals plc | AGRANT | 3,507 | — | — | +67.0% | Open the original filing on SEC.gov |
| Jun 30, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | AGRANT◆ | 33,450 | — | — | — | Open the original filing on SEC.gov |
| Jun 30, 2025 | YMAB | Y-mAbs Therapeutics, Inc. | AGRANT | 25,080 | — | — | +430.6% | Open the original filing on SEC.gov |